METHODIST RICHARDSON MEDICAL CENTER — History
CCN 450537 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$449M
Latest Revenue (FY2022)
+8.8%
Revenue CAGR (3yr)
14.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $379M | $419M | $449M | +7.1% | +8.8% |
| Operating Expenses | $311M | $350M | $383M | +9.5% | +11.0% |
| Operating Margin | 18.0% | 16.5% | 14.6% | -11.5% | -9.9% |
| Net Income | $68M | $69M | $66M | -5.2% | -2.0% |
| Licensed Beds | 247 | 247 | 247 | +0.0% | +0.0% |
| Total Patient Days | 64,881 | 68,835 | 67,801 | -1.5% | +2.2% |
| Medicare Day % | 26% | 23% | 22% | -1.4% | -8.2% |
| Medicaid Day % | 2% | 3% | 1% | -49.7% | -17.3% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.4% ($379M → $449M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.8%
This Hospital
+7.6%
State Avg
Latest Margin
14.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $484M | 12.9% |
| FY2024 (proj) | $519M | 11.2% |
| FY2025 (proj) | $554M | 9.6% |